Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Recs

0
Player Avatar Haugurafpeningum (85.94) Submitted: 11/8/2011 2:01:48 AM : Outperform Start Price: $2.19 OREX Score: +47.97

Technical Monthly

Featured Broker Partners


Advertisement